A sensitive and reproducible liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of amlodipine in human plasma, with gliclazide as an internal standard (IS). The analyte was extracted with ethyl acetate and analyzed on a Diamond C 18 (150 mm× 4.6 mm , 5 μm) column. The mobile phase was composed of methanol ? 10 mM ammonium acetate with gradient flow rates and gradient conditions. Amlodipine and IS were ionized by positive ion pneumatically assisted electrospray and detected in the multi-reaction monitoring (MRM) mode using precursor→productions of m/z 409.2→238.1, 294.1 and m/z 324.2→127.3, respectively. The specificity, matrix effect, recovery, sensitivity, linearity, accuracy, precision, and stabilities were all validated over the concentration range of 0.05 - 12 ng/m L. The 90% confidence in terval (CI) for AUC 0-t , AUC 0-∞ and C max ratios (test: reference) were all within 80 % - 125% interval proposed by FDA. It is concluded that the validated method can successfully fulfill the requirement of clinical bioequivalence study of amlodipine in healthy Chinese subjects after administration of amlodipine/losartan combination tablets and amlodipine tablets , and the test and reference tablets were bioequivalent.
W. C. Cushman, “Are There Benefits to Specific Anti- hypertensive Drug Therapy?” American Journal of Hy pertension, Vol. 16, No. 11, 2003, pp. 31S-35S.
C. Borghi and A. F. Cicero, “Rationale for the Use of a Fixed-Dose Combination in the Management of Hyper- tension: Efficacy and Tolerability of Lercanidipine/ Enalapril,” Clinical Drug Investigation, Vol. 30, No. 12, 2010, pp. 843-854. doi:10.1007/BF03256912
T. Philipp, T. R. Smith, R. Glazer, M. Wernsing, J. Yen, J. Jin, et al., “Two Multicenter, 8-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies Evaluating the Efficacy and Tolerability of Amlodipine and Valsartan in Combination and as Monotherapy in Adult Patients with Mild to Moderate Essential Hyper- tension,” Clinical Therapeutics, Vol. 29, No. 4, 2007, pp. 563-580. doi:10.1016/j.clinthera.2007.03.018
F. Kolocouri, Y. Dotsikas, C. Apostolou, C. Kousoulos and Y. L. Loukas, “Simultaneous Determination of Losartan, EXP-3174 and Hydrochlorothiazide in Plasma via Fully Automated 96-Well-Format-Based Solid-Phase Extraction and Liquid Chromatography-Negative Electrospray Tandem Mass Spectrometry,” Analytical and Bioanalytical Chemistry, Vol. 387, No. 2, 2007, pp. 593-601. doi:10.1007/s00216-006-0990-4
J. Y. Jia, M. Q. Zhang, Y. M. Liu, Y. Liu, G. Y. Liu, S. J. Li, et al., “Pharmacokinetics and Bioequivalence Evaluation of Two Losartan Potassium 50-mg Tablets: A Single-Dose, Randomized-Sequence, Open-Label, Two-Way Crossover Study in Healthy Chinese Male Volunteers,” Clinical Therapeutics, Vol. 32, No. 7, 2010, pp. 1387- 1395. doi:10.1016/j.clinthera.2010.06.018
J. Bhatt, S. Singh, G. Subbaiah, B. Shah, S. Kambli and S. Ameta, “A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Estimation of Amlodipine in Human Plasma,” Biomedical Chromatography, Vol. 21, No. 2, 2007, pp. 169-175. doi:10.1002/bmc.730
S. Tatar and S. Atmaca, “Determination of Amlodipine in Human Plasma by High-Performance Liquid Chromatography with Fluorescence Detection,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 758, No. 2, 2001, pp. 305-310. doi:10.1016/S0378-4347(01)00197-9
D. Murdoch and R. C. Heel, “Amlodipine. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Cardiovascular Disease,” Drugs, Vol. 41, No. 3, 1991, pp. 478-505. doi:10.2165/00003495-199141030-00009
F. Scharpf, K. D. Riedel, H. Laufen and M. Leitold, “Enantioselective Gas Chromatographic Assay with Electron-Capture Detection for Amlodipine in Biological Samples,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 655, No. 2, 1994, pp. 225-233. doi:10.1016/0378-4347(94)00068-9
S. C. Monkman, J. S. Ellis, S. Cholerton, J. M. Thomason, R. A. Seymour and J. R. Idle, “Automated Gas Chromatographic Assay for Amlodipine in Plasma and Gingival Crevicular Fluid,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 678, No. 2, 1996, pp. 360-364. doi:10.1016/0378-4347(95)00526-9
G. Bahrami and S. Mirzaeei, “Simple and Rapid HPLC Method for Determination of Amlodipine in Human Serum with Fluorescence Detection and Its Use in Pharmacokinetic Studies,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 36, No. 1, 2004, pp. 163-168. doi:10.1016/j.jpba.2004.05.016
A. Zarghi, S. M. Foroutan, A. Shafaati and A. Khoddam, “Validated HPLC Method for Determination of Amlodipine in Human Plasma and Its Application to Pharmacokinetic Studies,” Farmaco, Vol. 60, No. 9, 2005, pp. 789-792. doi:10.1016/j.farmac.2005.06.012
K. Shimooka, Y. Sawada and H. Tatematsu, “Analysis of Amlodipine in Serum by a Sensitive High-Performance Liquid Chromatographic Method with Amperometric Detection,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 7, No. 11, 1989, pp. 1267-1272. doi:10.1016/0731-7085(89)80130-X
M. Josefsson, A. L. Zackrisson and B. Norlander, “Sensitive High-Performance Liquid Chromatographic Analysis of Amlodipine in Human Plasma with Amperometric Detection and a Single-Step Solid-Phase Sample Preparation,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 672, No. 2, 1995, pp. 310-313. doi:10.1016/0378-4347(95)00231-7
K. K. Pandya, M. satia, T. P. Gandhi, I. A. Modi, R. I. Modi and B. K. Chakravarthy, “Detection and Determination of Total Amlodipine by High-Performance Thin- Layer Chromatography: A Useful Technique for Pharma- cokinetic Studies,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 667, No. 2, 1995, pp. 315-320. doi:10.1016/0378-4347(95)00016-C
Y. Feng, L. Zhang, Z. Shen, F. Pan and Z. Zhang, “Analysis of Amlodipine in Human Plasma by Liquid Chromatography-Mass Spectrometry,” Journal of Chromatographic Science, Vol. 40, No. 1, 2002, pp. 49-53.
B. Streel, C. Laine, C. Zimmer, R. Sibenaler and A. Ceccato, “Enantiomeric Determination of Amlodipine in Human Plasma by Liquid Chromatography Coupled to Tandem Mass Spectrometry,” Journal of Biochemical and Biophysical Methods, Vol. 54, No. 1-3, 2002, pp. 357-368. doi:10.1016/S0165-022X(02)00133-1
J. Shentu, L. Fu, H. Zhou, X. J. Hu, J. Liu, J. Chen, et al., “Determination of Amlodipine in Human Plasma Using Automated Online Solid-Phase Extraction HPLC-Tandem Mass Spectrometry: Application to a Bioequivalence Study of Chinese Volunteers,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 70, No. 2012, pp. 614-618.
M. Carvalho, C. H. Oliveira, G. D. Mendes, M. Sucupira, M. E. Moraes and G. De Nucci, “Amlodipine Bioequivalence Study: Quantification by Liquid Chromatography Coupled to Tandem Mass Spectrometry,” Biopharmaceutics & Drug Disposition, Vol. 22, No. 9, 2001, pp. 383- 390. doi:10.1002/bdd.282
A. K. Sarkar, D. Ghosh, A. Das, P. S. Selvan, K. V. Gowda, U. Mandal, et al., “Simultaneous Determination of Metoprolol Succinate and Amlodipine Besylate in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Method and Its Application in Bioequivalence Study,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 873, No. 1, 2008, pp. 77-85. doi:10.1016/j.jchromb.2008.07.040
A. V. Ramani, P. Sengupta and R. Mullangi, “Development and Validation of a Highly Sensitive and Robust LC-ESI-MS/MS Method for Simultaneous Quantitation of Simvastatin Acid, Amlodipine and Valsartan in Human Plasma: Application to a Clinical Pharmacokinetic Study,” Biomedical Chromatography, Vol. 23, No. 6, 2009, pp. 615-622. doi:10.1002/bmc.1161
V. B. Ravi, J. K. Inamadugu, N. R. Pilli, V. Sreenivasulu and V. Ponneri, “Simultaneous Determination of Telmisartan and Amlodipine in Human Plasma by LC-MS/MS and Its Application in a Human Pharmacokinetic Study,” Journal of Pharmaceutical Analysis, Vol. 2, No. 5, 2012, pp. 319-326. doi:10.1016/j.jpha.2012.03.008
X. Wei, G. Yang, L. Qi and Y. Chen, “Determination of Nicardipine and Amlodipine in Human Plasma Using On-Line Solid-Phase Extraction with a Monolithic Weak Cation-Exchange Column,” Talanta, Vol. 77, No. 3, 2009, pp. 1197-1202. doi:10.1016/j.talanta.2008.08.034
H. Chang, J. Li, X. Guan, F. Sun, Z. Qian, K. Bi, et al., “Simultaneous Determination of Amlodipine and Bisoprolol in Rat Plasma by a Liquid Chromatography/ Tandem Mass Spectrometry Method and Its Application in Pharmacokinetic Study,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 71, No. 2012, pp. 104-110.
Y. Ma, F. Qin, X. Sun, X. Lu and F. Li, “Determination and Pharmacokinetic Study of Amlodipine in Human Plasma by Ultra Performance Liquid Chromatography- Electrospray Ionization Mass Spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 43, No. 4, 2007, pp. 1540-1545. doi:10.1016/j.jpba.2006.11.015
C. T. Viswanathan, S. Bansal, B. Booth, A. J. DeStefano, M. J. Rose and J. Sailstad, et al., “Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays,” Pharmaceutical Research, Vol. 24, No. 10, 2007, pp. 1962-1973. doi:10.1007/s11095-007-9291-7
Y. Liu, J. Jia, G. Liu, S. Li, C. Lu and C. Yu, “Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of 10-mg Amlodipine Besylate: An Open-Label, Single-Dose, Randomized, Two-Way Crossover Study in Healthy Chinese Male Volunteers,” Clinical Therapeutics, Vol. 31, No. 4, 2009, pp. 777-783. doi:10.1016/j.clinthera.2009.04.013
F. Abad-Santos, J. Novalbos, M. A. Galvez-Mugica, S. Gallego-Sandin, S. Almeida, F. Vallee, et al., “Assessment of Sex Differences in Pharmacokinetics and Pharmacodynamics of Amlodipine in a Bioequivalence Study,” Pharmaceutical Research, Vol. 51, No. 5, 2005, pp. 445-452. doi:10.1016/j.phrs.2004.11.006